Related Experiment Video
Updated: May 16, 2025

06:18
Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production
Published on: August 18, 2023
2.3K
An Analysis of Monitoring Solutions for CAR T Cell Production
Arber Shoshi1,2,3, Yuchen Xia1,4, Andrea Fieschi1,5,6
1Graduate School of Excellence advanced Manufacturing Engineering (GSaME) University of Stuttgart Stuttgart Germany.
Healthcare Technology Letters
|May 14, 2025
Summary
Chimeric antigen receptor T cell (CAR T) therapy shows promise for cancer treatment but faces production challenges. This study reviews current measurement methods to improve CAR T cell manufacturing and on-line monitoring for greater efficiency.
Area of Science:
- Biotechnology
- Immunotherapy
- Oncology
Background:
- Chimeric antigen receptor T cell (CAR T) therapy is a promising cancer treatment modality.
- CAR T cell therapy involves genetically modifying patient T cells to target cancer cells.
- Current CAR T cell production is complex, costly, and requires specialized infrastructure.
Purpose of the Study:
- To provide an overview of measurement methods in CAR T cell production.
- To assess the current state of monitoring solutions for CAR T cell manufacturing.
- To identify opportunities for improving on-line monitoring in CAR T cell production.
Main Methods:
- Literature review of existing measurement techniques.
- Analysis of monitoring solutions across key CAR T cell production steps.
- Assessment of the potential for implementing on-line monitoring.
Main Results:
- Identified various measurement methods used in CAR T cell manufacturing.
- Highlighted the current limitations and potential of existing monitoring solutions.
- Pinpointed areas for enhancement in on-line monitoring capabilities.
Conclusions:
- Understanding current measurement methods is crucial for advancing CAR T cell production.
- Improved on-line monitoring can enhance the efficiency and effectiveness of CAR T cell therapies.
- This research supports the development of robust monitoring strategies for CAR T cell manufacturing.

